Return to Today's science sparks archives

2009-07-01

Fig 1. Regulation of Foxp3 expression.

Fig 1. Regulation of Foxp3 expression.
  • Lu LF, Rudensky A

  • Genes Dev. 2009 Jun 1;23(11):1270-82.

2009-07-02

Fig 2. Akt-1 expressions in breast cell line MCF-7.

Fig 2. Akt-1 expressions in breast cell line MCF-7.
  • Li R, Dai H, Wheeler TM, Sayeeduddin M, Scardino PT, Frolov A, Ayala GE

  • Clin Cancer Res. 2009 May 15;15(10):3568-73.

2009-07-06

Fig 2. Annual Age-adjusted Cancer Incidence and Death Rates for All Sites by Sex, United States, 1975ñ2005.

Fig 2. Annual Age-adjusted Cancer Incidence and Death Rates for All Sites by Sex, United States, 1975ñ2005.
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ

  • CA Cancer J Clin. 2009 Jun 25.

2009-07-07

Fig 3. miR-26a-expressing murine gliomas (P/26a). (A) Schematic of RCAS-miR constructs; CMV denotes CMV promoter, GFP denotes GFP cassette, and miR denotes miRNA domain.

Fig 3. miR-26a-expressing murine gliomas (P/26a). (A) Schematic of RCAS-miR constructs; CMV denotes CMV promoter, GFP denotes GFP cassette, and miR denotes miRNA domain.
  • Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC

  • Genes Dev. 2009 Jun 1;23(11):1327-37.

2009-07-08

Fig 2. TGF-fl induces the expression of NF-B in prostate cancer.

Fig 2. TGF-fl induces the expression of NF-B in prostate cancer.
  • Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C

  • Clin Cancer. 2009 May 15;15(10):3557-67.

2009-07-09

Fig 3. Waterfall graphs of prostate-specific antigen (PSA) response by cohort.

Fig 3. Waterfall graphs of prostate-specific antigen (PSA) response by cohort.
  • Morris MJ, Pandit-Taskar N, Carrasquillo J, Divgi CR, Slovin S, Kelly WK, Rathkopf D, Gignac GA, Solit D, Schwartz L, Stephenson RD, Hong C, Delacruz A, Curley T, Heller G, Jia X, O'Donoghue J, Larson S, Scher HI

  • J Clin Oncol. 2009 May 20;27(15):2436-42.

2009-07-10

Fig 1. The lambda epigenetic switch: the Cro gene is transcribed but the repressor gene (cI) is not. An early stage of lytic growth of the phage is shown.

Fig 1. The lambda epigenetic switch: the Cro gene is transcribed but the repressor gene (cI) is not. An early stage of lytic growth of the phage is shown.
  • Ptashne M

  • Curr Biol. 2009 Mar 24;19(6):R234-41.

2009-07-13

Fig 5. Anti-tumor effects of PU-H71 are associated with down-regulation of several Hsp90-regulated malignancy driving proteins.

Fig 5. Anti-tumor effects of PU-H71 are associated with down-regulation of several Hsp90-regulated malignancy driving proteins.
  • Caldas-Lopes E, Cerchietti L, Ahn JH, Clement CC, Robles AI, Rodina A, Moulick K, Taldone T, Gozman A, Guo Y, Wu N, de Stanchina E, White J, Gross SS, Ma Y, Varticovski L, Melnick A, Chiosis G

  • Proc Natl Acad Sci U S A. 2009 May 19;106(20):8368-73.

2009-07-14

Fig 4. Reciprocal changes in immunohistochemical CPI and cathepsin B staining in MV generated 4 d after s.c. injection of 106 TA3/St mammary carcinoma cells.

Fig 4. Reciprocal changes in immunohistochemical CPI and cathepsin B staining in MV generated 4 d after s.c. injection of 106 TA3/St mammary carcinoma cells.
  • Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, Nagy JA, Joyce J, Bogyo M, Kalluri R, Dvorak HF

  • Cancer Res. 2009 May 15;69(10):4537-44.

2009-07-15

Fig 1. Tie2/GFP expression by endothelial cells as visualized by multiphoton fluorescence microscopy.

Fig 1. Tie2/GFP expression by endothelial cells as visualized by multiphoton fluorescence microscopy.
  • Dunphy MP, Entenberg D, Toledo-Crow R, Larson SM

  • Microvasc Res. 2009 Jun;78(1):51-6.

2009-07-16

Fig 3c. Immunofluorescence of Pax3:Fkhr during disease progression (400x).

Fig 3c. Immunofluorescence of Pax3:Fkhr during disease progression (400x).
  • Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ, Prajapati SI, Gelfond JA, Chisholm GB, Michalek JE, Aronow BJ, Barr FG, Randall RL, Ladanyi M, Qualman SJ, Rubin BP, LeGallo RD, Wang C, Khan J, Keller C

  • Cancer Res. 2009 Apr 1;69(7):2902-11.

2009-07-17

Fig 3a. Expression matrix of 6 genes belonging to the oxidative phosphorylation pathway, which were downregulated in poor outcome tumors.

Fig 3a. Expression matrix of 6 genes belonging to the oxidative phosphorylation pathway, which were downregulated in poor outcome tumors.
  • Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, Paty PB, Gerald WL, Notterman DA, Domany E

  • Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7131-6.

2009-07-20

Fig 6a. Immunofluorescence microscopy analysis of cDO subcellular localization.

Fig 6a. Immunofluorescence microscopy analysis of cDO subcellular localization.
  • Deshaies F, Diallo DA, Fortin JS, O'Rourke HM, Pezeshki AM, Bellemare-Pelletier A, Raby N, BÈdard N, Brunet A, Denzin LK, Thibodeau J

  • Immunology. 2009 Jul;127(3):408-17.

2009-07-21

Fig 4. (AñL) Immunostaining of cytospins containing mononuclear cells from BM aspirates pulled from children with NB stage M.

Fig 4. (AñL) Immunostaining of cytospins containing mononuclear cells from BM aspirates pulled from children with NB stage M.
  • Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK; International neuroblastoma Risk Group Task Force

  • Br J Cancer. 2009 May 19;100(10):1627-37.

2009-07-22

Fig 1.  Isolation and characterization of brain metastatic variants.  i, GPF+ MDA231-BrM2a cells (arrowheads) arrested in brain capillaries (red, rhodamine dextran) 24 h after intracardiac injection into mice.

Fig 1. Isolation and characterization of brain metastatic variants. i, GPF+ MDA231-BrM2a cells (arrowheads) arrested in brain capillaries (red, rhodamine dextran) 24 h after intracardiac injection into mice.
  • Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, MassaguÈ J

  • Nature. 2009 Jun 18;459(7249):1005-9.

2009-07-23

Fig 4h. Src Enhances Metastasis Survival and Outgrowth in Bone Marrow. Representative TRAP staining. Arrows indicate positive staining.

Fig 4h. Src Enhances Metastasis Survival and Outgrowth in Bone Marrow. Representative TRAP staining. Arrows indicate positive staining.
  • Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, MassaguÈ J

  • Cancer Cell. 2009 Jul 7;16(1):67-78.

2009-07-24

Fig 2a. Conserved amino acids targeted for alanine scanning in S. pombe Spt4. Location of targeted residues in the Spt4 tertiary structure.

Fig 2a. Conserved amino acids targeted for alanine scanning in S. pombe Spt4. Location of targeted residues in the Spt4 tertiary structure.
  • Schwer B, Schneider S, Pei Y, Aronova A, Shuman S

  • RNA. 2009 Jul;15(7):1241-50.

2009-07-27

Fig 1c. Induction of chromosomal translocations in TOS4A cells.

Fig 1c. Induction of chromosomal translocations in TOS4A cells.
  • Brunet E, Simsek D, Tomishima M, DeKelver R, Choi VM, Gregory P, Urnov F, Weinstock DM, Jasin M

  • Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10620-5.

2009-07-28

Fig  6. Patient with metastatic ovarian cancer.

Fig 6. Patient with metastatic ovarian cancer.
  • Smith-Jones PM, Pandit-Taskar N, Cao W, O'Donoghue J, Philips MD, Carrasquillo J, Konner JA, Old LJ, Larson SM

  • Nucl Med Biol.2008 Apr;35(3):343-51.

2009-07-28

Fig 6. H&E staining of splenic lymphoma tissue in a p53 KO mouse and a p53/Elf4 DKO mouse, together with representative staining of Mdm2 and p16 protein by IHC.

Fig 6. H&E staining of splenic lymphoma tissue in a p53 KO mouse and a p53/Elf4 DKO mouse, together with representative staining of Mdm2 and p16 protein by IHC.
  • Sashida G, Liu Y, Elf S, Miyata Y, Ohyashiki K, Izumi M, Menendez S, Nimer SD

  • Mol Cell Biol.2009 Jul;29(13):3687-99.

2009-07-29

Fig 1. Dual-modality imaging using hNET and HSV1-tk reporter genes for monitoring different populations of antigen-specific CTLs.

Fig 1. Dual-modality imaging using hNET and HSV1-tk reporter genes for monitoring different populations of antigen-specific CTLs.
  • Ponomarev V

  • J Nucl Med.2009 Jun 12.

2009-07-30

Fig 2f. Neoplastic melanocytes are highlighted with aid of A103 immunostain.

Fig 2f. Neoplastic melanocytes are highlighted with aid of A103 immunostain.
  • Braga JC, Scope A, Klaz I, Mecca P, Gonz·lez S, Rabinovitz H, Marghoob AA

  • J Am Acad Dermatol. 2009 Aug;61(2):230-41.

2009-07-31

FIG 6. Tryptophan 96 and neighboring residues in the GLTP∑N-oleoyl LacCer complex.

FIG 6. Tryptophan 96 and neighboring residues in the GLTP∑N-oleoyl LacCer complex.
  • Zhai X, Malakhova ML, Pike HM, Benson LM, Bergen HR 3rd, Sugár IP, Malinina L, Patel DJ, Brown RE

  • J Biol Chem. 2009 May 15;284(20):13620-8.

2009-08-03

Fig 6. ART-27 expression and clinical outcome in AR-positive prostate cancer. A, ART-27 exhibits differential subcellular expression profiles in AR-positive prostate cancer.

Fig 6. ART-27 expression and clinical outcome in AR-positive prostate cancer. A, ART-27 exhibits differential subcellular expression profiles in AR-positive prostate cancer.
  • Nwachukwu JC, Mita P, Ruoff R, Ha S, Wang Q, Huang SJ, Taneja SS, Brown M, Gerald WL, Garabedian MJ, Logan SK

  • Cancer Res. 2009 Apr 1;69(7):3140-7.

2009-08-04

Fig 2. DNA ligases engage the nicked duplex as C-shaped protein clamps.

Fig 2. DNA ligases engage the nicked duplex as C-shaped protein clamps.
  • Shuman S

  • J Biol Chem. 2009 Jun 26;284(26):17365-9.

2009-08-05

Fig 12. Molecular architecture of Gal4BD-Spo11.

Fig 12. Molecular architecture of Gal4BD-Spo11.
  • Murakami H, Nicolas A

  • Mol Cell Biol. 2009 Jul;29(13):3500-16.

2009-08-06

Fig 2. Mean monthly untransfused hemoglobin levels in TI responders and nonresponders (N = 214).

Fig 2. Mean monthly untransfused hemoglobin levels in TI responders and nonresponders (N = 214).
  • Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF

  • Blood. 2008 Jan 1;111(1):86-93.

2009-08-06

Fig 6. YK-4-279 inhibits the growth of ESFT xenograft tumors.

Fig 6. YK-4-279 inhibits the growth of ESFT xenograft tumors.
  • Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L, Abaan OD, Chou TH, Dakshanamurthy S, Brown ML, Uren A, Toretsky JA

  • Nat Med. 2009 Jul;15(7):750-6.

2009-08-07

Fig 1c. Nontransgenic primary mammary cells grown in 3D cultures develop acini composed of polarized epithelial cells.

Fig 1c. Nontransgenic primary mammary cells grown in 3D cultures develop acini composed of polarized epithelial cells.
  • Jechlinger M, Podsypanina K, Varmus H

  • Genes Dev. 2009 Jul 15;23(14):1677-88.

2009-08-10

Fig 9. A Model that Illustrates mPar3 Regulation of Notch Signaling and Asymmetric Cell Division of Radial Glial Cells in the Developing Neocortex.

Fig 9. A Model that Illustrates mPar3 Regulation of Notch Signaling and Asymmetric Cell Division of Radial Glial Cells in the Developing Neocortex.
  • Bultje RS, Castaneda-Castellanos DR, Jan LY, Jan YN, Kriegstein AR, Shi SH

  • Neuron. 2009 Jul 30;63(2):189-202.

2009-08-11

Fig 1. HnRNP-L is a novel subunit of the human KMT3a complex. A, domain structure of human KMT3a and yeast KMT3.

Fig 1. HnRNP-L is a novel subunit of the human KMT3a complex. A, domain structure of human KMT3a and yeast KMT3.
  • Yuan W, Xie J, Long C, Erdjument-Bromage H, Ding X, Zheng Y, Tempst P, Chen S, Zhu B, Reinberg D

  • J Biol Chem. 2009 Jun 5;284(23):15701-7.

2009-08-12

Fig 6. Electron microscopic evaluation of morphology of polymer formed in glutamate without GTP.

Fig 6. Electron microscopic evaluation of morphology of polymer formed in glutamate without GTP.
  • Edler MC, Yang G, Katherine Jung M, Bai R, Bornmann WG, Hamel E

  • Arch Biochem Biophys. 2009 Jul 15;487(2):98-104.

2009-08-13

Fig 3e. Mammary cells without an oncogenic transgene can persist in the lung.

Fig 3e. Mammary cells without an oncogenic transgene can persist in the lung.
  • Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H

  • Science. 2008 Sep 26;321(5897):1841-4.

2009-08-13

Fig 2. A 90-year-old woman underwent PET/CT for initial staging of non-small-cell lung carcinoma and for guiding radiation therapy planning.

Fig 2. A 90-year-old woman underwent PET/CT for initial staging of non-small-cell lung carcinoma and for guiding radiation therapy planning.
  • Delbeke D, Schöder H, Martin WH, Wahl RL

  • Semin Nucl Med. 2009 Sep;39(5):308-40.

2009-08-17

Fig 4. Comparison of a right lateral beam's-eye view as seen in the planning scan and a CBCT scan.

Fig 4. Comparison of a right lateral beam's-eye view as seen in the planning scan and a CBCT scan.
  • Mechalakos J, Lee N, Hunt M, Ling CC, Amols HI

  • Med Dosim. 2009 Fall;34(3):250-5.

2009-08-18

Fig 6. Fewer chromosomal aberrations in the NHP6/293T-L-hTERT cells.

Fig 6. Fewer chromosomal aberrations in the NHP6/293T-L-hTERT cells.
  • Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, Zhou J, Schroeder L, Schneider-Broussard R, Shen J, Pathak S, Chang S, Tang DG

  • Int J Cancer. 2008 Apr 1;122(7):1483-95.

2009-08-18

Fig 2j. H2030 parental and H2030-BrM3 cells were implanted with Matrigel in the lung via intrathoracic inoculation.

Fig 2j. H2030 parental and H2030-BrM3 cells were implanted with Matrigel in the lung via intrathoracic inoculation.
  • Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, MassaguÈ J

  • Cell.2009 Jul 10;138(1):51-62.

2009-08-19

Fig 1. Prostatic core from TMA showing strong nuclear staining on immunochemistry for p53.

Fig 1. Prostatic core from TMA showing strong nuclear staining on immunochemistry for p53.
  • Kudahetti S, Fisher G, Ambroisine L, Foster C, Reuter V, Eastham J, M¯ller H, Kattan MW, Cooper CS, Scardino P, Cuzick J, Berney DM

  • BJU Int.2009 Jul;104(1):20-4.

2009-08-20

Fig 3. Plot of best radiological outcome by Response Evaluation Criteria in Solid Tumors (RECIST) by subject.

Fig 3. Plot of best radiological outcome by Response Evaluation Criteria in Solid Tumors (RECIST) by subject.
  • Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachère NE, Edgar MA, Schwartz LH, Qin LX, Antonescu CR, Schwartz GK

  • J Clin Oncol. 2009 Jul 1;27(19):3133-40.

2009-08-21

Fig 9a. Stacking between different layers in the human telomeric G-quadruplex Form 3 in K+ solution. View from the side looking into the medium groove 1 (M1).

Fig 9a. Stacking between different layers in the human telomeric G-quadruplex Form 3 in K+ solution. View from the side looking into the medium groove 1 (M1).
  • Lim KW, Amrane S, Bouaziz S, Xu W, Mu Y, Patel DJ, Luu KN, Phan AT

  • J Am Chem Soc. 2009 Apr 1;131(12):4301-9.

2009-08-24

Fig 1. Leiomyosarcoma samples with differentiation scores of 1 to 3.

Fig 1. Leiomyosarcoma samples with differentiation scores of 1 to 3.
  • Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, Del Muro XG

  • Semin Oncol. 2009 Aug;36(4):324-37.

2009-08-25

Fig 1. Thymic function decreases with age. (d) Islands of cortical and medullary tissue in aged thymus show signs of active thymopoiesis by CD1a and Ki67 immunostain.

Fig 1. Thymic function decreases with age. (d) Islands of cortical and medullary tissue in aged thymus show signs of active thymopoiesis by CD1a and Ki67 immunostain.
  • Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD

  • Trends Immunol.2009 Jul;30(7):366-73.

2009-08-26

An International Journal for Cancer Care.

An International Journal for Cancer Care.
  • Brown RF, Bylund CL, Kline N, De La Cruz A, Solan J, Kelvin J, Gueguen J, Eddington J, Kissane D, Passik S

  • Cancer Nurs.2009 May-Jun;32(3):E1-7

2009-08-27

Fig 1b. Copy number analysis in CRCs using SNP arrays. One sample showed a more focused gain from 8q24.13 to 8q24.3.

Fig 1b. Copy number analysis in CRCs using SNP arrays. One sample showed a more focused gain from 8q24.13 to 8q24.3.
  • Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Björklund M, Wei G, Yan J, Niittymäki I, Mecklin JP, Järvinen H, Ristimäki A, Di-Bernardo M, East P, Carvajal-Carmona L, Houlston RS, Tomlinson I, Palin K, Ukkonen E, Karhu A, Taipale J, Aaltonen LA

  • Nat Genet.2009 Aug;41(8):885-90.

2009-08-28

Fig 1. shRNA Screening Strategies: Well-by-Well versus Pooled Libraries.

Fig 1. shRNA Screening Strategies: Well-by-Well versus Pooled Libraries.
  • Sawyers CL

  • Cell. 2009 May 29;137(5):796-8.

2009-08-31

Fig 5a. Compared potency of the drug ouabain toward Y79 cells.

Fig 5a. Compared potency of the drug ouabain toward Y79 cells.
  • Antczak C, Kloepping C, Radu C, Genski T, M¸ller-Kuhrt L, Siems K, de Stanchina E, Abramson DH, Djaballah H

  • Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3065-73.

2009-09-01

Fig 5a. Integrin-specific mTORC1 signaling promotes cell survival.

Fig 5a. Integrin-specific mTORC1 signaling promotes cell survival.
  • López-Lago MA, Okada T, Murillo MM, Socci N, Giancotti FG

  • Mol Cell Biol. 2009 Aug;29(15):4235-49.

2009-09-02

Fig 1. The molecular mechanisms involved in the DNA damage response.

Fig 1. The molecular mechanisms involved in the DNA damage response.
  • Powell SN, Bindra RS

  • DNA Repair (Amst).2009 Sep 2;8(9):1153-65.

2009-09-03

Fig 4. Variation of the zero calibrator over an entire plate.

Fig 4. Variation of the zero calibrator over an entire plate.
  • Courtney JB, Harney R, Li Y, Lundell G, McMillin GA, Agarwal G, Juenke JM, Mathew A, Gonzalez-Espinoza R, Fleisher M, Salamone SJ

  • Ther Drug Monit.2009 Aug;31(4):489-94.

2009-09-04

Fig 1. Androgen receptor reactivation in prostate cancer progression

Fig 1. Androgen receptor reactivation in prostate cancer progression
  • Knudsen KE, Scher HI

  • Clin Cancer Res.2009 Aug 1;15(15):4792-8.

2009-09-08

Fig 3. C3f peptide degradation ladder.

Fig 3. C3f peptide degradation ladder.
  • Villanueva J, Nazarian A, Lawlor K, Tempst P

  • Nat Protoc.2009;4(8):1167-83.

2009-09-09

Fig 4. Overlay of red fluorescent carcinoembryonic antigen (CEA) antibody and green fluorescence protein (GFP) expression in OCUM-2MD3 cancer cells.

Fig 4. Overlay of red fluorescent carcinoembryonic antigen (CEA) antibody and green fluorescence protein (GFP) expression in OCUM-2MD3 cancer cells.
  • Fong SM, Lee MK, Adusumilli PS, Kelly KJ

  • Surgery.2009 Sep;146(3):498-505.

2009-09-10

Fig 4. Robust expression of MET in ASPS patient samples, with evidence of phosphorylation (activation) of MET in at least some cases. (Courtesy of S. Pilotti.)

Fig 4. Robust expression of MET in ASPS patient samples, with evidence of phosphorylation (activation) of MET in at least some cases. (Courtesy of S. Pilotti.)
  • Pires de Camargo V, van de Rijn M, de Alava E, Madoz-G˙rpide J, Pilotti S, von Mehren M, Pedeutour F, Maki RG, Rutkowski P, Thomas DM

  • Semin Oncol.2009 Aug;36(4):358-71.

2009-09-11

Fig 1. Demonstration of Hu133-specific T cells that have lytic activity and secrete IFN-?.

Fig 1. Demonstration of Hu133-specific T cells that have lytic activity and secrete IFN-?.
  • Roberts WK, Deluca IJ, Thomas A, Fak J, Williams T, Buckley N, Dousmanis AG, Posner JB, Darnell RB

  • J Clin Invest.2009 Jul;119(7):2042-51.

2009-09-14

Fig 2. Simple example of protein phosphorylation catalyzed by an enzyme and modulated by an inhibitor.

Fig 2. Simple example of protein phosphorylation catalyzed by an enzyme and modulated by an inhibitor.
  • Le Novère N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM, Bergman FT, Gauges R, Ghazal P, Kawaji H, Li L, Matsuoka Y, VillÈger A, Boyd SE, Calzone L, Courtot M, Dogrusoz U, Freeman TC, Funahashi A, Ghosh S, Jouraku A, Kim S, Kolpakov F, Luna A, Sahle S, Schmidt E, Watterson S, Wu G, Goryanin I, Kell DB, Sander C, Sauro H, Snoep JL, Kohn K, Kitano H

  • Nat Biotechnol.2009 Aug;27(8):735-41.

2009-09-15

Fig 2. E-cadherin trafficking in Drosophila. (A) E-cadherin (green) is located at the cell surface in the wild-type Drosophila pupal notum.

Fig 2. E-cadherin trafficking in Drosophila. (A) E-cadherin (green) is located at the cell surface in the wild-type Drosophila pupal notum.
  • Wirtz-Peitz F, Zallen JA

  • Curr Opin Genet Dev.2009 Aug;19(4):350-6.

2009-09-16

Figure 5. NF1 Genomic Alterations and Drug Sensitivity in Glioblastomas.

Figure 5. NF1 Genomic Alterations and Drug Sensitivity in Glioblastomas.
  • McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, Williams SM, Nghiemphu P, Liau LM, Cloughesy TF, Mischel PS, Parret A, Seiler J, Moldenhauer G, Scheffzek K, Stemmer-Rachamimov AO,

  • Cancer Cell.2009 Jul 7;16(1):44-54.

2009-09-18

Fig. 5 Scratch-induced migration of primary rat astrocytes.

Fig. 5 Scratch-induced migration of primary rat astrocytes.
  • Hall ACancer Metastasis Rev.

  • Cancer Metastasis Rev.2009 Jun;28(1-2):5-14.

2009-09-21

Fig 1. BM cells are recruited at the periphery of pulmonary metastatic lesions.

Fig 1. BM cells are recruited at the periphery of pulmonary metastatic lesions.
  • Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal VBiochim Biophys Acta.

  • Biochim Biophys Acta.2009 Aug;1796(1):33-40.

2009-09-22

Fig 1. Cone Precursor Markers in Developing Retina and Retinoblastoma Tumors. (AñD) Photoreceptor precursor markers (red) and Rb (green) in gestational week 16 human retina.

Fig 1. Cone Precursor Markers in Developing Retina and Retinoblastoma Tumors. (AñD) Photoreceptor precursor markers (red) and Rb (green) in gestational week 16 human retina.
  • Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D, Liu A, Jhanwar SC, Abramson DH, Cobrinik DCell.

  • Cell.2009 Jun 12;137(6):1018-31.

2009-09-23

Fig 1. CT scan of the pelvis (October 2004), showing a ring enhancing lesion of the right ovary.

Fig 1. CT scan of the pelvis (October 2004), showing a ring enhancing lesion of the right ovary.
  • Schiavon G, Maki R, Fornier MCurr Cancer Ther Rev.

  • Curr Cancer Ther Rev. 2009 May; 5(2):100-04.

2009-09-24

MRI/MRSI findings and molecular markers correlated well with each other and contributed incremental value to clinical variables in predicting prostate cancer recurrence.

MRI/MRSI findings and molecular markers correlated well with each other and contributed incremental value to clinical variables in predicting prostate cancer recurrence.
  • Shukla-Dave A, Hricak H, Ishill N, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo CClin Cancer Res.

  • Clin Cancer Res. 2009 Jun 1;15(11):3842-9.

2009-09-25

Fig 1. Manhattan plot of the P values in the pancreatic cancer GWAS.

Fig 1. Manhattan plot of the P values in the pancreatic cancer GWAS.
  • Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW Jr, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN Nat Genet.

  • Nat Genet. 2009 Sep;41(9):986-90.

2009-09-28

Fig 5. Transition structures for the reaction of vinylindene 1b with 1,4-quinone monoketal 2a without catalyst (top) and with TiCl4 (bottom).

Fig 5. Transition structures for the reaction of vinylindene 1b with 1,4-quinone monoketal 2a without catalyst (top) and with TiCl4 (bottom).
  • Hayden AE, DeChancie J, George AH, Dai M, Yu M, Danishefsky SJ, Houk KN J Org Chem.

  • J Org Chem. 2009 Sep 4;74(17):6770-6.

2009-09-29

Fig 4. Scatter plot of pixel Ktrans values obtained from single-image slice pharmacokinetic modeling analyses of a patient's DCE-MRI data.

Fig 4. Scatter plot of pixel Ktrans values obtained from single-image slice pharmacokinetic modeling analyses of a patient's DCE-MRI data.
  • Shukla-Dave A, Lee N, Stambuk H, Wang Y, Huang W, Thaler HT, Patel SG, Shah JP, Koutcher JA BMC Med Phys.

  • BMC Med Phys. 2009 Apr 7;9:4.

2009-09-30

Fig 6. A model for the function of Drg1 in the regulation of Bim protein stability.

Fig 6. A model for the function of Drg1 in the regulation of Bim protein stability.
  • Ambrosini G, Seelman SL, Schwartz GK Cancer Res.

  • Cancer Res. 2009 Aug 1;69(15):6115-21.

2009-10-01

Fig 1. Histological appearance of the recurrent tumor. A: Mature teratoma showing squamous epithelium lined cysts (Hematoxylin and Eosin stain at 40◊).

Fig 1. Histological appearance of the recurrent tumor. A: Mature teratoma showing squamous epithelium lined cysts (Hematoxylin and Eosin stain at 40◊).
  • Busse C, Nazeer T, Kanwar VS, Wolden S, LaQuaglia MP, Rosenblum M

  • Pediatr Blood Cancer. 2009 Oct;53(4):680-1.